Metabolomic signatures of intravenous racemic ketamine associated remission in treatment-resistant depression: A pilot hypothesis generating study

B Singh, S MahmoudianDehkordi, JLV Voort, X Han… - Psychiatry …, 2022 - Elsevier
In this pilot study (N= 9), we highlight new insights gained on ketamine's mechanism of
action where we have mapped biochemical processes that are affected within 40 min of …

Metabolomic signatures of intravenous racemic ketamine associated remission in treatment-resistant depression: A pilot hypothesis generating study

Mood Disorders Precision Medicine … - Psychiatry …, 2022 - mayoclinic.elsevierpure.com
In this pilot study (N= 9), we highlight new insights gained on ketamine's mechanism of
action where we have mapped biochemical processes that are affected within 40 min of …

Metabolomic signatures of intravenous racemic ketamine associated remission in treatment-resistant depression: A pilot hypothesis generating study

Mood Disorders Precision Medicine … - Psychiatry …, 2022 - scholars.uthscsa.edu
In this pilot study (N= 9), we highlight new insights gained on ketamine's mechanism of
action where we have mapped biochemical processes that are affected within 40 min of …

Metabolomic signatures of intravenous racemic ketamine associated remission in treatment-resistant depression: A pilot hypothesis generating study.

B Singh, S MahmoudianDehkordi, JLV Voort… - Psychiatry …, 2022 - europepmc.org
In this pilot study (N= 9), we highlight new insights gained on ketamine's mechanism of
action where we have mapped biochemical processes that are affected within 40 min of …

Metabolomic signatures of intravenous racemic ketamine associated remission in treatment-resistant depression: A pilot hypothesis generating study

B Singh, S MahmoudianDehkordi… - Psychiatry …, 2022 - pubmed.ncbi.nlm.nih.gov
In this pilot study (N= 9), we highlight new insights gained on ketamine's mechanism of
action where we have mapped biochemical processes that are affected within 40 min of …